Harnessing Beneficial Bacteria to Treat Chronic Inflammatory Skin Conditions
Using the discovery platform based on leading research from the Gallo Laboratory at the University of California San Diego, MatriSys has developed an innovative pipeline of prescription topical programs addressing multiple dermatological conditions. Our platform identifies beneficial bacteria derived from healthy human skin, which can be reintroduced to patients’ skin to restore homeostasis to the skin microbiome.
There is a huge unmet medical need in dermatology to reduce the use of steroids and broad-spectrum antibiotics.
News & Events
Biocom Global Life Science Partnering Conference
Tue, Feb 23, 2021 – Thu, Feb 25, 2021
©2021 MatriSys Bioscience